Gene therapy for sickle cell disease passes key preclinical test

A precision-engineered gene therapy virus, inserted into blood stem cells that are then transplanted, markedly reduced sickle-induced red-cell damage in mice with sickle cell disease, researchers from Dana-Farber/Boston Children’s Cancer and Blood Disorders Center reported in the Journal of Clinical Investigation.

Sickle cell gene therapy passes key preclinical test - Boston Children's Answers

The daily dilemmas of a student with sickle cell anaemia, Students

Dr.mrs jugesh saluja (@jugeshsaluja) / X

Health Archives — Page 34 of 107 — Harvard Gazette

Dr.mrs jugesh saluja (@jugeshsaluja) / X

Денис Савин (@withoutpassions) / X

Milwaukee Area Sickle Cell Support Group

gene therapy Archives - Page 4 of 5 - Boston Children's Answers

Transitioning to adult care for sickle cell disease: Ariyanna's journey - Boston Children's Answers

Gene editing shows promise as sickle cell therapy — Harvard Gazette

News & Events - latest news and happenings in the SCD community

Milwaukee Area Sickle Cell Support Group

Transitioning to adult care for sickle cell disease: Ariyanna's journey - Boston Children's Answers